Germ Cell Tumor and Testicular Tumor DNA Registry

Part of paid clinical trials in Basking Ridge, New Jersey.

Sponsor
Memorial Sloan Kettering Cancer Center
Study ID
NCT02099734
Status
Recruiting

Conditions

  • Germ Cell Tumor
  • Testicular Tumor

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Questionnaires — BEHAVIORAL
  • sample of blood or saliva — OTHER
    A sample of blood or saliva will be obtained for DNA extraction. Approximately 2-4 tubes of blood will be collected or one tablespoon of saliva. If a participant has already provided a DNA sample for another MSKCC IRB approved protocol, they may not need to provide an additional sample.

Study Details

This study is being done to create a registry to help us learn more about germ cell tumors (GCT) and other testicular tumors. The registry will include people with these tumors and also relatives and unrelated people without these tumors. This study will help us learn more about the prevention, diagnosis, treatment and outcome of these tumors. Studying relatives of patients and people unrelated to patients with GCT and other testicular tumors will help us understand why some people get these tumors and why some people don't.

Key Dates

Start date
Jan 31, 2014
Status verified
Feb 2026
Primary completion
Jan 31, 2028
Completion
Jan 31, 2028

Study Design

Enrollment
1,000 participants (estimated)

Arms

  • Arm: A: suspicion of germ cell tumor and/or a testicular mass
    patients with testicular GCTs and non-GCT testicular tumors, extragonadal male GCTs, and female GCTs,
  • Arm: B: family members of Group A
    relatives of patients with GCTs or testicular tumors
  • Arm: C: healthy controls unrelated to Group A or B
    healthy controls who are unrelated to Groups A or B and do not have a personal history of cancer nor a family history of GCT or non-GCT testicular tumors

Primary Outcome Measure

creation of a Germ Cell Tumor and testicular tumor registry [ Time Frame: 5 years ]

Central Contacts

  • Darren Feldman, MD
    646-422-4491
  • Joel Sheinfeld, MD
    646-422-4311

Locations (8)

FacilityCityStateZIPSite coordinators
Memorial Sloan Kettering Basking RidgeBasking RidgeNew Jersey-
Darren Feldman, MD
646-422-4491
Memorial Sloan Kettering MonmouthMiddletownNew Jersey07748
Darren Feldman, MD
646-422-4491
Memorial Sloan Kettering BergenMontvaleNew Jersey07645
Darren Feldman, MD
646-422-4491
Cold Springs Harbor Laboratory (Specimen Analysis)Cold Spring HarborNew York11724
Richard McCombie, PhD
516-367-8800
Memorial Sloan Kettering CommackCommackNew York11725
Darren Feldman, MD
646-422-4491
Memorial Sloan Kettering WestchesterHarrisonNew York10604
Darren Feldman, MD
646-422-4491
Memorial Sloan Kettering Cancer CenterNew YorkNew York10065
Darren Feldman, MD
646-422-4491
Joel Sheinfeld, MD
646-422-4311
Darren Feldman, MD (PRINCIPAL_INVESTIGATOR)
Memorial Sloan Kettering NassauUniondaleNew York11553
Darren Feldman, MD
646-422-4491

Find similar trials in Basking Ridge, NJ

Related Studies